- Lobbies for extension of patent rights, thus preventing the production of cheaper generics

- Increases lobbying expenditures and contributes to parties' campaign funds, thereby warding off government interference

- Introduces cheaper generics just when its patent is due to expire, thus making profits from both the original and the generic copy

- Plays on people's psychology: knowing fully well that even if they increase prices, customers will purchase the product they trust, even if it costs more

- Finances research on new drugs, findings are exaggerated to benefit them